CM - yes agreed, especially about the need for robust clinical data. Unfortunately, as we know from the last few years, this is very costly and slow. Onc is only getting enough cash for the next year or so, and thus is always going to be pushed financially. Where does the cash come from to expand and speed up the clinical trials?
CM - yes agreed, especially about the need for robust clinical...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $18.92K | 1.705M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 13619110 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 5063491 | 9 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |